Analyst price target range
Editas Medicine Price Target: $6.10 Average
Direct answer
Editas Medicine's average price target is $6.10.
The verified analyst range runs from $1.00 to $15.00.
The low target implies -57.4%, the high target implies +538.3%, and the range spans 595.7% of the current price.
Forecast evidence checked October 17, 2026.
Get free Editas Medicine email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $2.35
- Average price target
- $6.10
- High price target
- $15.00
- Low price target
- $1.00
- Low target gap
- -57.4%
- Target upside
- +159.6%
- High target gap
- +538.3%
- Target range width
- 595.7%
- Consensus rating
- Buy
- Analysts
- 10
- Evidence date
- October 17, 2026
- Valid through
- October 24, 2026
Explore related company data
Read the frequently asked questions.
What is Editas Medicine's average price target?
Editas Medicine's verified average price target is $6.10. The target range is $1.00 to $15.00.
How far are Editas Medicine's low and high targets from the recorded price?
The low target implies -57.4%, while the high target implies +538.3%.
How many analysts are included in Editas Medicine's consensus?
The verified consensus includes 10 analysts.
How is Editas Medicine's target upside or downside calculated?
The average target of $6.10 is divided by the recorded price of $2.35, then one is subtracted to produce +159.6%. This does not guarantee a future return.
When was Editas Medicine's analyst forecast verified?
The data was verified on 2026-10-17. The dataset is valid through 2026-10-24.